Biomarker-Driven Treatment of Advanced Gastrointestinal Malignancies

Download these slides from our 2020 ASCO-GI live satellite symposium on biomarker-driven treatment of advanced gastrointestinal malignancies including colorectal cancer and pancreatic cancer.
Pashtoon Kasi, MD
Michael J. Pishvaian, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.67 MB
Released: January 23, 2020


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by educational grants from
Array BioPharma Inc.
Bayer HealthCare Pharmaceuticals Inc.
Merck Sharp & Dohme Corp.

Related Content

Gain key clinical insights quickly with this short slideset from Clinical Care Options (CCO) on systemic therapy for advanced HCC

Mark Yarchoan, MD Released: November 30, 2020

From Clinical Care Options (CCO), watch video featuring expert perspectives on the use of immunotherapy for HCC

Lipika Goyal, MD Amit G. Singal, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 24, 2020 Expired: November 23, 2021

In slides from Clinical Care Options (CCO), experts provide insights on the optimal treatment of advanced HCC

Mark Yarchoan, MD Released: November 19, 2020

Review an expert commentary from Clinical Care Options (CCO) on choosing treatment for patients with HCC and Child-Pugh B cirrhosis

Mark Yarchoan, MD Released: November 18, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.